Additional file 8 of Exploring the effectiveness of molecular subtypes, biomarkers, and genetic variations as first-line treatment predictors in Asian breast cancer patients: a systematic review and meta-analysis
Creators: name: Bahrin, Nurul Wafiqah Saipol
name: Matusin, Siti Nur Idayu
name: Mustapa, Aklimah
name: Huat, Lu Zen
name: Perera, Sriyani
name: Hamid, Mas Rina Wati Haji Abdul
Publisher: name: figshare
Year: 2024
Subjects: subject: Medicine
subject: Cell Biology
subject: Genetics
subject: FOS: Biological sciences
subject: Pharmacology
subject: Biotechnology
subject: Biological Sciences not elsewhere classified
subject: Cancer
subject: Plant Biology
subject: Computational Biology

description: Additional file 8. Publication Bias. Supplementary Figure 8.1. Funnel plot of pooled pCR outcome of Asian breast cancer patients treated with TA chemotherapy. Funnel plot assessing the publication bias in evaluating the effect of HER2E and Luminal, combined in breast cancer pCR outcome of patients treated with TA regimen in the neoadjuvant setting. Supplementary Figure 8.2. Funnel plot of pooled pCR outcome of Asian breast cancer patients treated with TA chemotherapy. Funnel plot assessing the publication bias in evaluating the effect of TNBC and Luminal, combined in breast cancer pCR outcome of patients treated with TA regimen in the neoadjuvant setting. Supplementary Figure 8.3. Funnel plot of pooled pCR outcome of Asian breast cancer patients treated with TA chemotherapy. Funnel plot assessing the publication bias in evaluating the effect of TNBC and HER2E in breast cancer pCR outcome of patients treated with TA regimen in the neoadjuvant setting. Supplementary Figure 8.4. Funnel plot of pooled pCR outcome of Asian breast cancer patients treated with TP chemotherapy. Funnel plot assessing the publication bias in evaluating the effect of HER2E and Luminal, combined in breast cancer pCR outcome of patients treated with TP regimen in the neoadjuvant setting. Supplementary Figure 8.5. Funnel plot of pooled pCR outcome of Asian breast cancer patients treated with TA chemotherapy. Funnel plot assessing the publication bias in evaluating the effect of ER in breast cancer pCR outcome of patients treated with TA regimen in the neoadjuvant setting. Supplementary Figure 8.6. Funnel plot of pooled pCR outcome of Asian breast cancer patients treated with TA chemotherapy. Funnel plot assessing the publication bias in evaluating the effect of HER2 in breast cancer pCR outcome of patients treated with TA regimen in the neoadjuvant setting. Supplementary Figure 8.7. Funnel plot of pooled pCR outcome of Asian breast cancer patients treated with TA chemotherapy. Funnel plot assessing the publication bias in evaluating the effect of Ki-67 in breast cancer pCR outcome of patients treated with TA regimen in the neoadjuvant setting. Supplementary Figure 8.8. Funnel plot of pooled pCR association of Asian breast cancer patients in the neoadjuvant setting. Funnel plot assessing the publication bias in evaluating the effect of ER+ and ER- (adjusted OR association) in breast cancer pCR outcome of patients treated in the neoadjuvant setting. Supplementary Figure 8.9. Funnel plot of pooled pCR association of Asian breast cancer patients in the neoadjuvant setting. Funnel plot assessing the publication bias in evaluating the effect of PR- and PR+ (adjusted OR association) in breast cancer pCR outcome of patients treated in the neoadjuvant setting. Supplementary Figure 8.10. Funnel plot of pooled pCR association of Asian breast cancer patients in the neoadjuvant setting. Funnel plot assessing the publication bias in evaluating the effect of HER2- and HER2+ (crude OR association) in breast cancer pCR outcome of patients treated in the neoadjuvant setting. Supplementary Figure 8.11. Funnel plot of pooled pCR association of Asian breast cancer patients in the neoadjuvant setting. Funnel plot assessing the publication bias in evaluating the effect of HER2+ and HER2- (adjusted OR association) in breast cancer pCR outcome of patients treated in the neoadjuvant setting. Supplementary Figure 8.12. Funnel plot of pooled pCR association of Asian breast cancer patients in the neoadjuvant setting. Funnel plot assessing the publication bias in evaluating the effect of high and low Ki-67 (crude OR association) in breast cancer pCR outcome of patients treated in the neoadjuvant setting. Supplementary Figure 8.13. Funnel plot of pooled pCR association of Asian breast cancer patients in the neoadjuvant setting. Funnel plot assessing the publication bias in evaluating the effect of high and low Ki-67 (adjusted OR association) in breast cancer pCR outcome of patients treated in the neoadjuvant setting.